Zoromonte LC Kid Syrup is a pediatric formulation combining Levocetirizine (2.5mg/5ml) and Montelukast (4mg/5ml), designed to provide effective relief from allergic conditions in children. Levocetirizine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis and urticaria. Montelukast, a leukotriene receptor antagonist, blocks the action of leukotrienes, which are inflammatory mediators involved in asthma and allergic rhinitis pathophysiology, thus helping to prevent bronchoconstriction and airway inflammation. The combination of these two agents offers a dual mechanism of action, addressing both histamine-mediated and leukotriene-mediated allergic responses, making it suitable for managing seasonal allergic rhinitis, perennial allergic rhinitis, and mild to moderate asthma symptoms in pediatric patients. Zoromonte LC Kid Syrup is generally well-tolerated, with a favorable safety profile when used as directed. It is recommended to administer the syrup once daily, preferably in the evening, to optimize therapeutic outcomes. As with any medication, it should be used under medical supervision, and caregivers should monitor for any adverse reactions or hypersensitivity. This formulation provides a convenient and palatable option for children requiring combination therapy for allergic conditions.